Live Quote · NASDAQRXRXHealthcare· Biotechnology

Recursion Pharmaceuticals, Inc.

$2.45▼ 9.93%($-0.27)
MKT CAP $1.53BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
47
Valuation
25
Profitability
90
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RXRX research report →

Analyst Price Target
$5.90+140.8% vs. today

Range $5.9 – $5.9

Analyst RatingHold
4 Buy6 Hold0 Sell

Price Chart

-34.42% · this period
$4.96$3.74$2.52Nov 20May 26Nov 20
52-Week Range0% of range
Low
$2.44
Current
$2.45
High
$5.24

AI analysis · Last refreshed November 19, 2026 · Live quote · Not investment advice